- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06540040
Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care
A Comparative Study to Assess the Efficacy of Postoperative Dressing in the Prevention of Early Surgical Site Complication and Facilitation of Early Mobilization After Orthopaedic Surgeries on Hip and Knee
Title: Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care: A Randomized Controlled Trial
Objective:
The primary objective of this study is to evaluate and compare the efficacy of advanced wound dressings versus traditional gauze-based dressings in post-operative orthopedic care. The study aims to assess various parameters including patient comfort, pain management, ease of application, exudate management, and the incidence of early surgical site complications.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Title: Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care: A Randomized Controlled Trial
Brief Summary:
This study aims to compare the efficacy of advanced wound dressings with traditional gauze-based dressings in post-operative orthopedic care. The study evaluates patient comfort, pain management, ease of application, exudate management, and the incidence of early surgical site complications.
Study Type: Interventional (Clinical Trial)
Study Design: Randomized Controlled Single-Centre Open-Label Study
Primary Purpose: Treatment
Study Start Date: August 10, 2022
Study Completion Date: December 10, 2022
Primary Completion Date: December 10, 2022
Estimated Enrollment: 320 participants
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Interventions:
Participants undergoing orthopedic surgical procedures were randomized into four groups:
Group A: Aquacel Ag (Hydrofibre wound dressing with ionic silver) Group B: OPSITE (Transparent waterproof cotton pad with high Moisture Vapour Transmission Rate) Group C: MEPILEX POST OP BORDER (4-layer foam dressing with flex technology) Group D: Traditional dressing with gauze pieces, surgical pads, and porous paper adhesive strips
Objectives:
To assess the incidence of early surgical site complications such as blisters, infection, maceration, rashes, redness, swelling, and dehiscence at days 3, 7, and 14.
To determine the pain and discomfort experienced by patients during dressing changes using a visual analog scale.
To evaluate the ability to perform activities of daily living comfortably. To assess nurses' ease of application and removal of the dressings.
Outcome Measures:
Primary Outcome Measures: Incidence of surgical site complications at days 3, 7, and 14.
Secondary Outcome Measures: Pain levels during dressing changes, comfort and mobility in daily activities, ease of application and removal of the dressings, and patient satisfaction.
Data Collection Methods:
Data were collected using a semi-structured questionnaire validated by experts. The questionnaire included a wound assessment checklist, a 10-point Likert scale for patient comfort and mobility, a Visual Analog Scale for pain, and a rating scale for nurses' ease of application and removal.
Statistical Analysis:
Categorical variables were presented as numbers and percentages. Continuous variables were presented as mean ± SD and median values. Data normality was checked using the Kolmogorov-Smirnov test. Quantitative variables were analyzed using ANOVA and Kruskal-Wallis test with post hoc tests as appropriate.
Qualitative variables were analyzed using the Chi-Square test or Fisher's exact test for cells with expected values less than 5.
A p-value of less than 0.05 was considered statistically significant.
Ethics and Registration:
Detailed Description:
This study evaluates the comparative efficacy of different wound dressings used in post-operative orthopedic care. The focus is on advanced dressings such as Aquacel Ag, OPSITE, and MEPILEX POST OP BORDER, compared to traditional gauze-based dressings. The study measures various parameters including patient comfort, pain during dressing changes, ease of application and removal by nurses, and management of wound exudate. Data were collected at three time points: days 3, 7, and 14 post-surgery. The results aim to provide insights into the best practices for post-operative wound management in orthopedic patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
New Delhi, India, 110010
- Base Hospital Delhi cantt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 18 and 90 years Undergoing orthopedic surgical procedures, elective or trauma, with a surgical wound size of more than 5 cm Provided informed consent
Exclusion Criteria:
- Open fractures Revision surgeries Established infections Ongoing pharmacological anticoagulation prophylaxis Predisposing skin conditions Known allergy or hypersensitivity to any of the constituents of the dressings Any associated systemic injury precluding early mobilization Unwillingness to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aquacel Ag
Participants in this group will receive Aquacel Ag, a Hydrofibre wound dressing consisting of non-woven sodium carboxymethylcellulose fibres integrated with ionic silver.
This dressing is designed to provide a moist wound environment and has antimicrobial properties to help reduce the risk of infection.
The dressing will be applied post-operatively and changed as per the standardized protocol.
|
Aquacel Ag is a Hydrofibre wound dressing composed of non-woven sodium carboxymethylcellulose fibers integrated with ionic silver.
It is designed to provide a moist wound environment and has antimicrobial properties to help reduce the risk of infection.
The dressing will be applied post-operatively and changed according to a standardized protocol.
Other Names:
|
|
Experimental: OPSITE
Participants in this group will receive OPSITE, a transparent waterproof cotton pad with a high Moisture Vapour Transmission Rate.
This dressing is intended to provide a protective barrier while allowing moisture vapor to escape, helping to maintain an optimal wound healing environment.
The dressing will be applied post-operatively and changed according to the standardized protocol.
|
OPSITE is a transparent waterproof dressing with a high Moisture Vapour Transmission Rate.
It is intended to provide a protective barrier while allowing moisture vapor to escape, maintaining an optimal wound healing environment.
The dressing will be applied post-operatively and changed according to a standardized protocol.
Other Names:
|
|
Experimental: MEPILEX POST OP BORDER
Participants in this group will receive MEPILEX POST OP BORDER, a 4-layer foam dressing with flex technology.
This advanced dressing is designed to provide superior absorption and conformability, helping to manage exudate and protect the wound site.
The dressing will be applied post-operatively and changed as per the standardized protocol.
|
MEPILEX POST OP BORDER is a 4-layer foam dressing designed with flex technology for superior absorption and conformability.
It helps manage exudate and protects the wound site.
The dressing will be applied post-operatively and changed according to a standardized protocol.
Other Names:
|
|
Active Comparator: Traditional Dressing
Participants in this group will receive traditional wound dressings consisting of gauze pieces, surgical pads, and porous paper adhesive strips.
This type of dressing is commonly used in post-operative care to absorb exudate and protect the wound site.
The dressing will be applied post-operatively and changed according to the standardized protocol.
|
Traditional dressing involves the use of gauze pieces, surgical pads, and porous paper adhesive strips.
This type of dressing is commonly used in post-operative care to absorb exudate and protect the wound site.
The dressing will be applied post-operatively and changed according to a standardized protocol.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Early Surgical Site Complications
Time Frame: Day 3, Day 7, Day 14 post-surgery
|
The primary outcome measure will be the incidence of early surgical site complications, including blisters, skin margin infection, maceration, rashes, redness, swelling, and wound dehiscence.
These complications will be assessed at three time points: day 3, day 7, and day 14 post-surgery.
|
Day 3, Day 7, Day 14 post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Levels During Dressing Changes
Time Frame: Day 3, Day 7, Day 14 post-surgery
|
Pain levels experienced by patients during dressing changes will be assessed using a Visual Analog Scale (VAS) from 0 to 10, where 0 corresponds to no pain and 10 corresponds to unbearable pain.
This will be measured at day 3, day 7, and day 14 post-surgery.
|
Day 3, Day 7, Day 14 post-surgery
|
|
Patient Comfort and Mobility
Time Frame: Day 3, Day 7, Day 14 post-surgery
|
Patient comfort and ability to perform activities of daily living will be assessed using a 0-to-10-point scale, where 0 indicates absolute discomfort and 10 indicates no limitation due to the dressing.
This will be measured at day 3, day 7, and day 14 post-surgery.
|
Day 3, Day 7, Day 14 post-surgery
|
|
Nurses' Ease of Application and Removal of Dressings
Time Frame: Day 3, Day 7, Day 14 post-surgery
|
Nurses will rate the ease of application and removal of the dressing using a 0-to-10-point scale, considering factors such as time taken, difficulty, and any issues encountered during the process.
This will be measured at day 3, day 7, and day 14 post-surgery.
|
Day 3, Day 7, Day 14 post-surgery
|
|
Patient Satisfaction Levels
Time Frame: Day 14 post-surgery
|
Patient satisfaction with the dressing will be assessed using a structured questionnaire.
This will be measured at day 14 post-surgery.
|
Day 14 post-surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Amresh Ghai, MS (Ortho), Base Hospital Delhi cantt
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 88/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthopaedics Wound Dressings
-
Seoul National University HospitalCompletedBiological DressingsKorea, Republic of
-
Corporacion Parc TauliDepartment of Health, Generalitat de Catalunya; Fundació Parc TaulíCompletedHip Surgery | Knee Surgery | Nursing | Occlusive DressingsSpain
-
Aswan University HospitalCompletedSurgical Flap | Negative-Pressure DressingsEgypt
-
Associazione Infermieristica per lo studio delle...Artsana S.p.a.UnknownBurns | Burn Injury | Occlusive Dressings | Hydrogel BandageItaly
-
The University of QueenslandPoitiers University Hospital; Queensland Children's Hospital; Griffith University and other collaboratorsCompletedWound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site ReactionsAustralia, France
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPostoperative Pain | Postoperative Pain Management | Postoperative Pain in Orthopaedics
-
Shandong Suncadia Medicine Co., Ltd.CompletedPostoperative Pain in OrthopaedicsChina
-
Brigham and Women's HospitalCompletedSurgical Wound | Wound Heal | Wound of Skin | Wound OpenUnited States
-
ConvaTec Inc.WithdrawnSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
Chandan SenUniversity of Colorado, DenverRecruitingInfections | Wound Infection | Wound Heal | Wound of Skin | Wound Healing DelayedUkraine
Clinical Trials on Aquacel Ag
-
Golden Jubilee National HospitalConvaTec Inc.Withdrawn
-
ConvaTec Inc.Bristol-Myers SquibbCompletedSplit-Thickness Donor Sites.United States
-
IWK Health CentreActive, not recruiting
-
National Taiwan University HospitalUnknownUlcer | Head and Neck Cancer | Head and Neck Neoplasms | WoundsTaiwan
-
Molnlycke Health Care ABCompleted
-
Tactile Systems Technology, Inc.Terminated
-
ConvaTec Inc.CompletedLeg UlcersUnited Kingdom
-
Columbia UniversityKinetic Concepts, Inc.CompletedWound ComplicationUnited States, Canada
-
University of California, IrvineTerminated
-
Dr Angela OatesConvaTec Inc.CompletedDiabetes | Chronic Foot WoundsUnited Kingdom